文献速递颈动脉与弓上血管

年龄对经颈动脉血运重建、经股动脉颈动脉支架与颈动脉内膜切除术后院内结局的影响

The impact of age on in-hospital outcomes after transcarotid artery revascularization, transfemoral carotid artery stenting, and carotid endarterectomy.
PubMed 文献 · J Vasc Surg · 2020-02-05

TCAR术后结局在不同年龄组间无差异,且与CEA相当;在≥80岁患者中,TCAR较TFCAS显著降低卒中、卒中/死亡及卒中/死亡/心肌梗死风险。

要点

  • TCAR术后院内结局在不同年龄组间无显著差异。
  • 在≥80岁患者中,TCAR较TFCAS显著降低卒中及 composite 结局风险。
  • TCAR与CEA在不同年龄组间结局无显著差异。

核心结论

  • TCAR是不受年龄限制的相对安全术式,在老年患者中优势更明显。
  • 在≥77岁患者中,TCAR较TFCAS显著降低院内卒中风险,且不依赖症状状态和其他合并症。
  • 对于高手术风险的老年患者,TCAR应优先于TFCAS。

研究设计与样本

  • 队列包括3152例TCAR、10381例TFCAS和61650例CEA。
  • 按年龄分为≤70岁、71-79岁和≥80岁三组,采用logistic回归并引入治疗类型与年龄的交互项比较院内结局。

主要发现

  • TCAR术后院内卒中/死亡率在≤70岁、71-79岁和≥80岁组分别为1.4%、1.9%和1.5%(P = .55)。
  • 在≥80岁患者中,TCAR较TFCAS降低卒中风险(4.7% vs 1%;OR 0.28;95%CI 0.12-0.65;P < .01)。
  • 在≥80岁患者中,TCAR较TFCAS降低卒中/死亡风险(4.6% vs 1.5%;OR 0.35;95%CI 0.20-0.62;P < .001)。
  • 在≥80岁患者中,TCAR较TFCAS降低卒中/死亡/心肌梗死风险(5.3% vs 2.5%;OR 0.24;95%CI 0.12-0.47;P < .001)。
  • TFCAS较TCAR的卒中/死亡比值比在77岁时为2.0(95%CI 1.4-3.0;P < .01),在90岁时为3.0(95%CI 1.6-5.8;P < .01;交互P = .08)。

临床怎么用

  • 对老年颈动脉狭窄患者,选择血运重建方式时应考虑年龄对TFCAS风险的影响。
  • 对于高手术风险的老年患者,可优先选择TCAR而非TFCAS。
  • TCAR在不同年龄组中均可考虑,其院内结局不受年龄显著影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Previous data showed superior outcomes of carotid endarterectomy (CEA) compared with transfemoral carotid artery stenting (TFCAS) in elderly patients because of an increased stroke risk in TFCAS-treated patients. Transcarotid artery revascularization (TCAR) with flow reversal was developed to mitigate the maneuvers at highest risk for causing stroke during TFCAS, such as manipulation of a diseased aortic arch and crossing of the carotid lesion before deployment of an embolic protection device. This study aimed to compare the association between age and outcomes after TCAR, TFCAS, and CEA. METHODS: All patients undergoing carotid procedures in the Society for Vascular Surgery Vascular Quality Initiative database between 2015 and November 2018 were included. Patients were divided into three different age groups (≤70 years, 71-79 years, and ≥80 years). In-hospital outcomes after TCAR vs TFCAS and after TCAR vs CEA were compared in each age group by introducing an interaction term between treatment type and age in the logistic regression analysis after adjustment for patients' preoperative characteristics. RESULTS: The study cohort included 3152 TCAR, 10,381 TFCAS, and 61,650 CEA cases. The absolute and adjusted in-hospital outcomes after TCAR did not change across the different age groups. The rates of in-hospital stroke/death after TCAR were 1.4% in patients ≤70 years vs 1.9% in patients 71 to 79 years and 1.5% in patients ≥80 years (P = .55). Comparison of TCAR to CEA across different age groups showed no significant differences in outcomes, and no interaction was noted between treatment and age in predicting in-hospital stroke/death (P = .80). In contrast, TCAR was associated with a 72% reduction in stroke risk (4.7% vs 1%; odds ratio [OR], 0.28; 95% confidence interval [CI], 0.12-0.65; P < .01), 65% reduction in risk of stroke/death (4.6% vs 1.5%; OR, 0.35; 95% CI, 0.20-0.62; P < .001), and 76% reduction in the risk of stroke/death/myocardial infarction (5.3% vs 2.5%; OR, 0.24; 95% CI, 0.12-0.47; P < .001) compared with TFCAS in patients ≥80 years. Moreover, compared with TCAR, the odds of stroke/death after TFCAS doubled at 77 years (OR, 2.0; 95% CI, 1.4-3.0; P < .01) and tripled at 90 years (OR, 3.0; 95% CI, 1.6-5.8; P < .01; P value for the interaction = .08). CONCLUSIONS: TCAR is a relatively safe procedure regardless of the patient's age. The advantages of TCAR become more pronounced in elderly patients, with significant reductions in in-hospital stroke compared with TFCAS in patients ≥77 years old, independent of symptomatic status and other medical comorbidities. These findings suggest that TCAR should be preferred to TFCAS in elderly patients who are at high surgical risk.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Dakour-Aridi H, Kashyap VS, Wang GJ, et al. The impact of age on in-hospital outcomes after transcarotid artery revascularization, transfemoral carotid artery stenting, and carotid endarterectomy. J Vasc Surg. 2020. PMID: 32035784. doi:10.1016/j.jvs.2019.11.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。